Dr. Raphael is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4915 Auburn Ave
Suite 202
Bethesda, MD 20814Phone+1 301-907-3442Fax+1 301-907-6835
Education & Training
- National Institutes of Health Clinical CenterFellowship, Allergy and Immunology, 1984 - 1989
- Johns Hopkins University/Bayview Medical CenterResidency, Internal Medicine, 1981 - 1984
- Emory University School of MedicineClass of 1981
Certifications & Licensure
- MD State Medical License 1983 - 2025
- American Board of Allergy and Immunology Allergy & Immunology
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 6 citationsRandomized, double-blind trial evaluating the efficacy and safety of fluticasone propionate and fluticasone propionate/salmeterol delivered via multidose dry powder in...Gordon D. Raphael, Gloria Yiu, Anat Sakov, Siyu Liu, Cynthia F. Caracta
The Journal of Asthma. 2018-06-01 - 4 citationsRandomized trial to assess the efficacy and safety of beclomethasone dipropionate breath-actuated inhaler in patients with asthma.Nancy K. Ostrom, Gordon D. Raphael, Jeffrey Tillinghast, Lisa Hickey, Calvin J. Small
Allergy and Asthma Proceedings. 2018-03-09 - 6 citationsTwelve- and 52-week safety of albuterol multidose dry powder inhaler in patients with persistent asthma.Gordon D. Raphael, Herminia Taveras, Harald Iverson, C.D. O'Brien, David Miller
The Journal of Asthma. 2016-02-07
Press Mentions
- Novel Fluticasone Propionate MDPI Improves Quality of Life, Asthma SymptomsMarch 4th, 2017
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: